Comment: Patient Focused Drug Development: Methodologic and Other Challenges Related to Patient Experience Data
Submitted to the Food and Drug Administration and Department of Health and Human Services
Policy
Comment: Health Care Market Consolidation and Private Equity Funds
Submitted to U.S. Department of Justice, Department of Health and Human Services, and Federal Trade Commission
Print:
On May 6th, 2024, University of Pennsylvania Leonard Davis Institute of Health Economics (LDI) Executive Director Rachel M. Werner, MD, PhD submitted a public comment in response to a Request for Information (RFI) on consolidation in health care and the effects of transactions conducted by private equity funds or other alternative asset managers, health systems, or private payers. Werner provides an overview of the evidence on the impacts of health care consolidation of hospitals, with a specific focus on health equity, including low-income Medicaid beneficiaries.
More on Policy at LDI
Briefing: The Impact of Repealing the Centers for Medicare and Medicaid Services Minimum Staffing Rule on Patient Outcomes
Presented to U.S. Senator Elizabeth Warren
Briefing: Health Impacts of Tax Incentives for Low-Income Families
Presented to Members of the Pennsylvania General Assembly and Governor Shapiro’s Office
Testimony: Front Lines of the Fentanyl Crisis: Supporting Communities and Combating Addiction through Prevention and Treatment
Delivered to the United States Senate Committee on Finance
Comment: Development of a Universal Symbol for Language Assistance Services in Health Settings
Submitted to the Office of Minority Health, U.S. Department of Health and Human Services
Comment: Opportunities to Improve Substance Use Disorder Care in the Federal Health Programs
Submitted to U.S. Senate Committee on Finance